EUVIMEDEUVIMED entdecken
Crossref

Implementation Science Methodology for the Successful Introduction of High‐Dose Methotrexate for the Treatment of Pediatric Mature B‐Cell Non‐Hodgkin Lymphoma in a Resource‐Limited Setting

Hutton Chapman iD, Paul S Ntemi, Richard Mahene, Dativa Zelama, Jacqueline Kamanga, Goodluck Nchasi iD, Heronima Kashaigili, Kristin Schroeder iD

Pediatric Blood & Cancer · 2026

DOI: 10.1002/1545-5017.70019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Hutton Chapman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Duke University Hospital, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Methotrexate, Lymphoma, B-Cell, Implementation Science, Health Resources. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite the excellent outcomes achieved for pediatric mature B‐cell non‐Hodgkin lymphoma (MB‐NHL) in high‐income countries, outcomes remain very poor in low‐ and middle‐income countries. High‐dose methotrexate (HD‐MTX), which is highly efficacious for the disease, is still not commonly used in low‐resource settings due to the potential for treatment‐associated toxicity. Though there have been more recent reports of successful use of HD‐MTX in resource‐limited settings, there are no reports to date regarding the methodology used to safely introduce HD‐MTX in these environments. Subsequently, at our treatment center in northern Tanzania, we endeavored to utilize implementation science methodology to elucidate generalizable methods to allow for a safe introduction of HD‐MTX in a resource‐limited setting. Procedure The Active Implementation Frameworks were utilized as a starting point to generate an initial implementation plan. Intervention fit was assessed, and resource mapping and cost analysis were completed. Key stakeholders were identified and engaged. Novel educational strategies, decision support tools, and protocol fidelity monitoring systems were developed.

Results

Following completion of all planning and education activities, use of a new HD‐MTX containing MB‐NHL protocol began in October of 2024. As of June 2025, 27 cycles of HD‐MTX have been given to a cumulative total of 10 patients. Few protocol deviations have occurred, and only one Grade III non‐hematologic adverse event has been reported.

Conclusions

The use of implementation science methodology allowed a careful introduction of the use of HD‐MTX for the treatment of pediatric MB‐NHL in a resource‐limited setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateLymphoma, B-CellImplementation ScienceHealth ResourcesAntimetabolites, AntineoplasticHumansChildFemaleMaleChild, PreschoolDeveloping CountriesTanzaniaAdolescentResource-Limited Settings

Stichwörter der Autor:innen

Burkitt lymphomaLMICdiffuse large B‐cell lymphomahigh‐dose methotrexateimplementation sciencemature B‐cell non‐Hodgkin lymphoma

Substanzen

MethotrexateAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Duke University Hospital, Durham, North Carolina, USA.
  • Duke Global Health Institute, Durham, North Carolina, USA.
  • Bugando Medical Centre, Mwanza, Tanzania.
  • Catholic University of Allied and Health Sciences, Mwanza, Tanzania.

ORCID-Profile: Hutton Chapman, Goodluck Nchasi, Kristin Schroeder

Zitieren

APA

Chapman, H., Ntemi, P. S., Mahene, R., Zelama, D., Kamanga, J., Nchasi, G., Kashaigili, H., & Schroeder, K. (2026). Implementation Science Methodology for the Successful Introduction of High‐Dose Methotrexate for the Treatment of Pediatric Mature B‐Cell Non‐Hodgkin Lymphoma in a Resource‐Limited Setting. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70019

Vancouver

Chapman H, Ntemi PS, Mahene R, Zelama D, Kamanga J, Nchasi G, et al. Implementation Science Methodology for the Successful Introduction of High‐Dose Methotrexate for the Treatment of Pediatric Mature B‐Cell Non‐Hodgkin Lymphoma in a Resource‐Limited Setting. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70019

BibTeX
@article{Chapman2026,
  author = {Chapman, Hutton and Ntemi, Paul S and Mahene, Richard and Zelama, Dativa and Kamanga, Jacqueline and Nchasi, Goodluck and Kashaigili, Heronima and Schroeder, Kristin},
  title = {Implementation Science Methodology for the Successful Introduction of High‐Dose Methotrexate for the Treatment of Pediatric Mature B‐Cell Non‐Hodgkin Lymphoma in a Resource‐Limited Setting},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/1545-5017.70019}
}
Kostenlos starten →